Page 29 - THE SOUTH CHINA BUSINESS JOURNAL
P. 29
August 22, 2019, Gilead Caption: A bird’s
Sciences celebrated the grand eye view of Gilead’s
opening of its Guangzhou Branch. Headquarter in Foster
Since the inception of its China City, California
commercial operation in 2016, this
research-based biopharma company Vice President and China General Manager of Gilead
has already established its China Sciences, at the Guangzhou Branch opening ceremony.
headquarter in Shanghai as well
as two branches in Beijing and Improving health through
Chengdu respectively. The launch scientific innovation
of its Guangzhou Branch in August
2019 was another milestone that Founded in Foster City, California, U.S. in 1987,
Gilead has achieved which showcases Gilead Sciences is a research-based biopharmaceutical
its significant development in China company that discovers, develops and commercializes
over the short time span as well its innovative therapeutics to address unmet medical
strong commitment towards the needs. Within 30 years since its establishment, the
patients in China in the long run. company had already been listed among the Top 10
pharmaceutical companies worldwide. Moreover,
Chronic and infectious disease is Gilead was ranked at the top in 2019 Pharmaceutical
a huge challenge facing the public Innovation Index. It is at the first place in terms
health in both China and the United of employee satisfaction in a survey from Business
States. With the vision “to advance Insider. In 2018, the total revenue of Gilead was 22.1
therapeutics against life-threatening billion USD.
diseases worldwide”, Gilead has
already brought eight of its global Gilead has launched, to date, more than 25 marketed
innovative therapeutics to patients products worldwide, including a number of category
in China to help address the unmet firsts: the complete treatment regimen for HIV in a
medical needs in the areas of HBV, once-daily single pill; the only PrEP (pre-exposure
HCV and HIV. “We will continue prophylaxis) treatment approved by the U.S. Food and
to work very closely with various Drug Administration (FDA); the first oral medication
partners to help improve the patient for curing chronic hepatitis C infections; and some of
access and to contribute to the the most recognized medicines, such as Tamiflu, the
development of public health in first pill to treat the flu.
China,” said Rogers Luo, Global
Nowadays, Gilead is operating in more than 35
countries with about 11,000 employees around the
world. With more than 50% of Gilead’s staff are
scientists, the company is focusing on continuously
innovating therapeutics in the areas of HIV/AIDS,
South China Business Journal 26
Sciences celebrated the grand eye view of Gilead’s
opening of its Guangzhou Branch. Headquarter in Foster
Since the inception of its China City, California
commercial operation in 2016, this
research-based biopharma company Vice President and China General Manager of Gilead
has already established its China Sciences, at the Guangzhou Branch opening ceremony.
headquarter in Shanghai as well
as two branches in Beijing and Improving health through
Chengdu respectively. The launch scientific innovation
of its Guangzhou Branch in August
2019 was another milestone that Founded in Foster City, California, U.S. in 1987,
Gilead has achieved which showcases Gilead Sciences is a research-based biopharmaceutical
its significant development in China company that discovers, develops and commercializes
over the short time span as well its innovative therapeutics to address unmet medical
strong commitment towards the needs. Within 30 years since its establishment, the
patients in China in the long run. company had already been listed among the Top 10
pharmaceutical companies worldwide. Moreover,
Chronic and infectious disease is Gilead was ranked at the top in 2019 Pharmaceutical
a huge challenge facing the public Innovation Index. It is at the first place in terms
health in both China and the United of employee satisfaction in a survey from Business
States. With the vision “to advance Insider. In 2018, the total revenue of Gilead was 22.1
therapeutics against life-threatening billion USD.
diseases worldwide”, Gilead has
already brought eight of its global Gilead has launched, to date, more than 25 marketed
innovative therapeutics to patients products worldwide, including a number of category
in China to help address the unmet firsts: the complete treatment regimen for HIV in a
medical needs in the areas of HBV, once-daily single pill; the only PrEP (pre-exposure
HCV and HIV. “We will continue prophylaxis) treatment approved by the U.S. Food and
to work very closely with various Drug Administration (FDA); the first oral medication
partners to help improve the patient for curing chronic hepatitis C infections; and some of
access and to contribute to the the most recognized medicines, such as Tamiflu, the
development of public health in first pill to treat the flu.
China,” said Rogers Luo, Global
Nowadays, Gilead is operating in more than 35
countries with about 11,000 employees around the
world. With more than 50% of Gilead’s staff are
scientists, the company is focusing on continuously
innovating therapeutics in the areas of HIV/AIDS,
South China Business Journal 26
